SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000920465-14-000084
Filing Date
2014-07-25
Accepted
2014-07-25 16:19:54
Documents
4
Period of Report
2014-07-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjuly25th2014.htm 8-K 31673
2 EXHIBIT underwritingagreement.htm EX-1.1 279106
3 EXHIBIT exhibit518-k2014july.htm EX-5.1 10881
4 gdlogo.jpg GRAPHIC 4607
  Complete submission text file 0000920465-14-000084.txt   329501
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 14994516
SIC: 2836 Biological Products, (No Diagnostic Substances)